# Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome

> **NCT04625556** · — · RECRUITING · sponsor: **Yonsei University** · enrollment: 3000 (estimated)

## Conditions studied

- Urological Malignancies
- Prostate Cancer
- Renal Cell Cancer
- Bladder Cancer
- Ureter Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04625556
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-19
- **Primary completion:** 2030-10
- **Final completion:** 2030-10
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04625556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04625556, "Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04625556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*